MedPath

The possibility of 5-HIAA,serotonin metabolites, as a biomaker of depressed COPD patients.

Phase 2
Conditions
copd and depression
Registration Number
JPRN-UMIN000021326
Lead Sponsor
Tohoku university graduate school of medicine
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Complete: follow-up complete
Sex
All
Target Recruitment
70
Inclusion Criteria

Not provided

Exclusion Criteria

depressed COPD patients by under medical treatment

Study & Design

Study Type
Interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
the plasma levels of 5-HIAA before and after respiratory rehabilitation
Secondary Outcome Measures
NameTimeMethod
score of CES-D before and after respiratory rehabilitation
© Copyright 2025. All Rights Reserved by MedPath